Back to TEVA Stock Lookup

Teva Pharma (TEVA) –

Jan 26, 2015 03:42 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 26
Jan 26, 2015 03:23 PM Teva Receives FDA Approval for First Generic Nexium® Delayed-Release Capsules in the United States
Jan 26, 2015 02:31 PM Teva Pharma (TEVA): FDA Approves First Generic Esomeprazole
Jan 26, 2015 10:47 AM Notable Analyst Rating Changes 1/26: (BBBY) (GRMN) (FNFG) Upgraded; (HCP) (STT) (LYB) Downgraded
Jan 26, 2015 07:17 AM Berenberg Starts Teva Pharma (TEVA) at Sell
Jan 23, 2015 04:01 PM Teva (TEVA) said to rebuff Pfizer (PFE) approach - Bloomberg
Jan 23, 2015 07:23 AM Maxim Group Downgrades Momenta Pharmaceuticals (MNTA) to Sell
Jan 20, 2015 05:21 PM Market Wrap: China GDP Growth Slowed 2014; Netflix Int'l Growth Continues; Starboard Pushes for Staples Deal
Jan 20, 2015 03:18 PM Notable 52-Week Highs and Lows 1/20: (NVAX) (UNH) (TEVA) High; (AMD) (GTE) (REXX) Low
Jan 20, 2015 01:02 PM Mylan (MYL) Comments on Supreme Court Decision Related to '808 Patent on Copaxone (TEVA)
Jan 20, 2015 11:41 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 20
Jan 20, 2015 11:26 AM UPDATE: Teva Pharma (TEVA) Wins High Court Ruling that May Delay Copaxone Rivals - Bloomberg
Jan 20, 2015 11:25 AM Teva Announces U.S. Supreme Court Decision to Reverse Federal Circuit Court’s Judgment on COPAXONE® 20 mg/mL Case and Remand for Further Review
Jan 20, 2015 10:11 AM Teva Pharma (TEVA) Taps 52-Week High
Jan 15, 2015 01:13 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 15
Jan 15, 2015 12:57 PM Teva to Report Fourth Quarter 2014 Financial Results on February 5, 2015
Jan 8, 2015 09:37 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 08
Jan 8, 2015 08:00 AM Teva to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Jan 8, 2015 08:00 AM Xenon Pharmaceuticals Outlines Key Anticipated Milestones for 2015
Jan 7, 2015 06:18 AM Teva Pharma (TEVA) Announces U.S. Launch of Diovan
Jan 7, 2015 06:01 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Jan 06
Jan 6, 2015 05:40 PM Teva Launches Generic Diovan® in the United States
Dec 30, 2014 07:02 AM OncoGenex Pharma (OGXI) Will Reacquire Custirsen Rights from Teva Pharma (TEVA)
Dec 30, 2014 07:00 AM OncoGenex to Regain Rights to Custirsen from Teva
Dec 23, 2014 12:12 PM Guggenheim Names Top 2015 Picks in Specialty Pharmaceuticals; Sees Continued M&A (VRX) (ZTS) (NEOT)
Dec 23, 2014 08:11 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 23
Dec 23, 2014 08:02 AM Teva Pharma (TEVA) Receives FDA Approval of GRANIX Injection
Dec 23, 2014 08:00 AM FDA Approves Teva’s GRANIX® (tbo-filgrastim) Injection for Self-Administration
Dec 22, 2014 08:22 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 22
Dec 22, 2014 08:00 AM Teva to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference
Dec 19, 2014 09:08 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 19
Dec 19, 2014 08:02 AM Teva Pharma (TEVA) Receives FDA Approval of QNASL as AR-Related Nasal Symptoms Treatment
Dec 19, 2014 08:00 AM Teva Announces FDA Approval of QNASL® (Beclomethasone Dipropionate) Nasal Aerosol for Treatment of Children with Seasonal and Perennial Allergic Rhinitis
Dec 12, 2014 10:59 AM Notable Analyst Rating Changes 12/12: (GPRO) (TEVA) (DTE) Upgraded; (GDP) (ORCL) (MS) Downgraded
Dec 12, 2014 08:21 AM Sterne Agee Upgrades Teva Pharma (TEVA) to Buy
Dec 11, 2014 05:20 PM Market Wrap: Retail Sales Robust in Nov.; Staples, Office Depot Deal in the Works?; Two Notable IPOs Launch
Dec 11, 2014 07:03 AM Teva Pharma (TEVA) Guides FY15 Revenue Below Expectations
Dec 11, 2014 07:00 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 11
Dec 11, 2014 07:00 AM Teva Provides 2015 Business Outlook
Dec 11, 2014 06:01 AM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 10
Dec 10, 2014 08:35 AM Teva Pharma (TEVA) Launches First FDA-Approved, Genetic Celebrex
Dec 10, 2014 08:30 AM Teva Announces Launch of First Generic Celebrex® Capsules in the United States
Dec 8, 2014 06:39 AM Teva Pharma (TEVA) PT Raised to $66 at BofA/Merrill Lynch
Dec 4, 2014 12:01 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 04
Dec 4, 2014 10:29 AM Teva Receives Positive Outcome in Europe for Three-Times-a-Week COPAXONE® (Glatiramer Acetate) 40 mg/ml for the Treatment of Relapsing Forms of Multiple Sclerosis (RMS)
Dec 1, 2014 04:27 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 01
Dec 1, 2014 03:46 PM Teva to Host 2015 Business Outlook Conference Call and Webcast on December 11, 2014
Dec 1, 2014 12:15 PM Form 6-K TEVA PHARMACEUTICAL INDU For: Dec 01
Dec 1, 2014 12:02 PM Teva Pharma (TEVA) Launches Generic Exforge HCT Tabs (NVS)
Dec 1, 2014 11:50 AM Teva Announces Launch of Generic Exforge HCT® Tablets in the United States

Back to TEVA Stock Lookup